STAAR Surgical Company
staar.comWhat Do They Do?
Sells implantable lenses and delivery systems for vision-correction surgery to ophthalmic surgeons, hospitals and surgery centers.
10-K for FY2025, filed Mar 3, 2026STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to…View ↗
We market and sell our ICLs for refractive surgery to treat myopia (nearsightedness) as our “EVO” family of lenses. We believe our EVO…View ↗
We market our products to a variety of health-care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals…View ↗
Who Are Their Customers?
Ophthalmologists are the primary users; hospitals, surgery centers, vision centers and distributors are also among the customers. STAAR sells directly in some markets, combines its representatives with independent distributors in others, and uses independent distributors elsewhere.
10-K for FY2025, filed Mar 3, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 12, 2026
$8.1MView ↗
- ▲ Now profitable
- vs −$16.8M in Q2 FY2025
-
Aug 6, 2026
Warren Foust appointed president and CEO
Sources
8-K, filed Aug 6, 2026
On August 4, 2026, STAAR Surgical Company (the “Company” or “STAAR”) announced that the Company’s Board of Directors (the “Board”)…View ↗
Exit from cataract products
The older report described sales of cataract lenses, preloaded injectors and related products; the latest says those sales were phased out, with the business centered on ICLs.
10-K for FY2022, filed Feb 23, 2023 10-K for FY2025, filed Mar 3, 2026Intraocular Lenses (IOLs). We sell in parts of Asia and parts of Europe a “Preloaded Injector” with an acrylic IOL packaged and shipped in…View ↗
In most of the countries where STAAR sells cataract IOLs, government agencies reimburse most or all of the cost of cataract surgery and…View ↗
Other Surgical Products. We sell injector parts to our acrylic lens supplier for their preloaded acrylic cataract IOL that they sell under…View ↗
STAAR generates worldwide revenue almost exclusively from sales of our ICLs. In prior years, we also recorded Other Products revenue, which…View ↗
Who Do They Compete With?
Competes with Alcon, Johnson & Johnson, Bausch & Lomb, Carl Zeiss Meditec, Biotech Vision Care, Care Group, Eyebright, and Ophtec
10-K for FY2025, filed Mar 3, 2026We believe our primary competition in selling the ICL to patients seeking surgery to correct refractive conditions lies not in similar…View ↗
Loading...
